Journal
CEREBRAL CORTEX
Volume 11, Issue 5, Pages 452-462Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cercor/11.5.452
Keywords
-
Categories
Funding
- NIMH NIH HHS [MH57683] Funding Source: Medline
Ask authors/readers for more resources
The interactions between N-methyl-D-aspartate (NMDA) and D-1 dopamine receptors in the rat prefrontal cortex were examined using whole-cell recordings from pyramidal neurons. The effects of NMDA, the D-1 agonist SKF38393, or both compounds combined were tested on measures of cell excitability. Both NMDA (10-100 muM) and SKF38393 (5-10 muM) independently increased the number at spikes and decreased the latency of the first spike evoked by intracellular depolarizing current pulses. Combining low doses of NMDA (5 muM) and SKF38393 (2 muM) resulted in a marked increase of cell excitability. This synergism was blocked by SCH23390, protein kinase A (PKA) inhibitors, and the Ca2+ chelator BAPTA, and reduced by nifedipine, These results indicate the presence of a dopamine-glutamate interaction in the prefrontal cortex at the postsynaptic level, by which D1 dopamine receptors may maintain NMDA-mediated responses in prefrontal cortical pyramidal neurons through both a PKA-dependent pathway and Ca2+-dependent mechanisms.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available